Entry ID |
Link Type |
Entity ID |
Title |
554
|
Sequence mapping |
1 |
Complete Sequence-Specific 1H NMR Assignments for Human Insulin |
555
|
Sequence mapping |
1 |
Complete Sequence-Specific 1H NMR Assignments for Human Insulin |
556
|
Sequence mapping |
1 |
Two-Dimensional NMR and Photo-CIDNP Studies of the Insulin Monomer: Assignment
of Aromatic Resonances with Application to Protein Folding, Structure, and
Dynamics |
557
|
Sequence mapping |
1 |
Two-Dimensional NMR and Photo-CIDNP Studies of the Insulin Monomer: Assignment
of Aromatic Resonances with Application to Protein Folding, Structure, and
Dynamics |
883
|
Sequence mapping |
1 |
1H Nuclear Magnetic Resonance Study of the Histidine Residues of Insulin |
884
|
Sequence mapping |
1 |
1H Nuclear Magnetic Resonance Study of the Histidine Residues of Insulin |
936
|
Sequence mapping |
1 |
Two-dimensional NMR studies on des-pentapeptide-insulin Proton resonance
assignments and secondary structure analysis |
937
|
Sequence mapping |
1 |
Two-dimensional NMR studies on des-pentapeptide-insulin Proton resonance
assignments and secondary structure analysis |
994
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
996
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
998
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1000
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1002
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1004
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1006
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1008
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1010
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1012
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1014
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1015
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1016
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1018
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1020
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1022
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1025
|
Sequence mapping |
1 |
Sequence-specific 1H-NMR assignments for the aromatic region of several
biologically active, monomeric insulins including native human insulin |
1344
|
Sequence mapping |
1 |
Toward the Solution Structure of Human Insulin: Sequential 2D 1H NMR Assignment
of a Des-pentapeptide Analogue and Comparison with Crystal Structure |
1444
|
Sequence mapping |
1 |
2D 1H NMR Studies of Monomeric Insulin |
1585
|
Sequence mapping |
1 |
Proton Nuclear Magnetic Resonance Study of the B9(Asp)Mutant of Human Insulin
Sequential Assignment and Secondary Structure |
1587
|
Sequence mapping |
1 |
Proton Nuclear Magnetic Resonance Study of the B9(Asp)Mutant of Human Insulin
Sequential Assignment and Secondary Structure |
1632
|
Sequence mapping |
1 |
Comparative 2D NMR Studies of Human Insulin and Des-pentapeptide Insulin:
Sequential Resonance Assignment and Implications for Proteins Dynamics and
Receptor Recognition |
1633
|
Sequence mapping |
1 |
Comparative 2D NMR Studies of Human Insulin and Des-pentapeptide Insulin:
Sequential Resonance Assignment and Implications for Proteins Dynamics and
Receptor Recognition |
1761
|
Sequence mapping |
1 |
Heteronuclear 2D NMR Studies of an Engineered Insulin Monomer: Assignment and
Characterization of the Receptor-Binding Surface by Selective 2H and 13C
Labeling with Application to Protein Design |
6623
|
Sequence mapping |
1 |
Chemical Shift Assignments for Proinsulin C-Peptide |
11016
|
Sequence mapping |
1 |
Humal Insulin Mutant B31Lys -B32Arg |
15464
|
Sequence mapping |
1 |
NMR STRUCTURE OF HUMAN INSULIN MONOMER IN 35% CD3CN ZINC FREE, 50 STRUCTURES |
15464
|
Sequence mapping |
2 |
NMR STRUCTURE OF HUMAN INSULIN MONOMER IN 35% CD3CN ZINC FREE, 50 STRUCTURES |
16026
|
Sequence mapping |
1 |
ENHANCING THE ACTIVITY OF INSULIN BY STEREOSPECIFIC UNFOLDING |
16027
|
Sequence mapping |
1 |
ENHANCING THE ACTIVITY OF INSULIN BY STEREOSPECIFIC UNFOLDING |
16343
|
Sequence mapping |
1 |
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLU-B21-D-GLU, HIS-B10 ASP PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES |
16663
|
Sequence mapping |
1 |
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY-B8-D-ALA, HIS-B10-2 ASP PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES |
16915
|
Sequence mapping |
1 |
Human Insulin Mutant A22Gly-B31Lys-B32Arg |
17107
|
Sequence mapping |
1 |
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY-B20-D-ALA, GLY-B23 2 PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES |
17803
|
Sequence mapping |
1 |
Human Insulin Mutant A22Gly-B31Arg |
17803
|
Sequence mapping |
2 |
Human Insulin Mutant A22Gly-B31Arg |
18858
|
Sequence mapping |
1 |
Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solutions. |
18859
|
Sequence mapping |
1 |
Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions. |
18921
|
Sequence mapping |
1 |
Structure of [L-HisB24] insulin analogue at pH 1.9 |
18923
|
Sequence mapping |
1 |
Structure of [L-HisB24] insulin analogue at pH 8.0 |
18924
|
Sequence mapping |
1 |
Structure of [D-HisB24] insulin analogue at pH 1.9 |
18925
|
Sequence mapping |
1 |
Structure of [D-HisB24] insulin analogue at pH 8.0 |
19822
|
Sequence mapping |
1 |
NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin |
19978
|
Sequence mapping |
1 |
Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue |
20052
|
Sequence mapping |
1 |
Solution NMR Structure of Insulin A-chain peptide |
20053
|
Sequence mapping |
1 |
Solution NMR structure of Insulin A-chain variant peptide |